If passed today, retail weed stores would open in the summer of 2023. The post Mexico has a new marijuana legalization bill. Here’s what’s in it appeared first on Leafly. Read More: Mexico has a new marijuana legalization bill. Here’s what’s in itContinue Reading
“GW’s claim construction victory bodes very well for their ultimate success in defending this lawsuit.” By Larry Sandell, Mei & Mark, LLP Last week, U.S. District Judge Alan D. Albright issued a claim construction order favoring GW Pharmaceuticals in the high-stakes, high-profile cannabis patent litigation brought by Canopy Growth Corporation.Continue Reading
The U.S. Department of Agriculture (USDA) on Thursday announced that it has taken steps to improve insurance policies for hemp businesses, making them more flexible in response to stakeholder feedback. USDA’s Risk Management Agency (RMA) said it is making it so hemp producers are no longer mandated to deliver theirContinue Reading
As congressional lawmakers work to advance federal marijuana legalization, a bipartisan duo on Thursday filed a bill that would incentivize states and local governments to expunge cannabis records in their jurisdictions. Reps. Dave Joyce (R-OH) and Alexandria Ocasio-Cortez (D-NY) are sponsoring the legislation, titled the Harnessing Opportunities by Pursuing ExpungementContinue Reading
The Drug Enforcement Administration (DEA) has yet again increased its quota for the legal production of illegal controlled substances like psilocybin, MDMA and DMT for research purposes in 2022. In a notice published in the Federal Register on Thursday, the agency made another quota adjustment for certain psychedelics. This hasContinue Reading
Cannabis advocates in South Dakota saw a real victory in last year’s elections, as voters approved an amendment to the state constitution legalizing adult use. But it was immediately met with legal challenge. And now the state’s top court has definitively squelched it. The South Dakota Supreme Court on Nov.Continue Reading
The top federal drug researcher says even she is reluctant to conduct studies on Schedule I drugs like marijuana because of the “cumbersome” rules that scientists face when investigating them. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), made the comments during a Wednesday forum moderated byContinue Reading
Congressional Black Caucus Foundation marijuana internships; Groups urge cannabis banking in NDAA; Austin decrim ballot initiative; VA access push Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. (function() { window.mc4wp =Continue Reading
